EuroSIDA Publications 2026

  1. Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. Kraef C, Ryom L, Kirk O; writing group and the RESPOND study group.
    Eur Respir J. 2026;67(3):2502523.  Abstract

  2. Cancer burden and risk factors among women with HIV: a multi-regional study from the D:A:D and RESPOND cohort collaborations.  Han WM, Neesgaard B, Knappik M, Cavassini M, Abela IA, Timiryasova A, Greenberg L, Martin C, Mussini C, Wit F, Sabin C, Castagna A, Abutidze A, El-Sadr W, Bonnet F, Sarcletti M, Carlander C, Hachfeld A, Weis N, Vannappagari V, Rogatto FP, Young LA, Hosein SR, Ryom L, Petoumenos K; D:A:D; RESPOND collaborations.
    EClinicalMedicine. 2026;91:103739.  Abstract

Total number of publications: 355

In Press

  1. Trends in AIDS-defining illnesses among people living with HIV in clinical care in Europe: results from the EuroSIDA multicentre cohort study (2003 - 2024). Wendy P Bannister, Joanne Reekie, Lars Peters, Cristiana Oprea, Raimonda Matulionytė, Marie- Angélique De Scheerder, Alina Kryshchuk, Line Dahlerup Rasmussen, Fiona Burns, Kai Zilmer, Elżbieta Jablonowska, Christoph Boesecke, Alexandra Zagalo, Esteban Martinez, Marcel Stoeckle, János Szlávik, Jasna Topalovic, Georgios Adamis, Justyna D Kowalska, Daria Podlekareva, for the EuroSIDA study.
    Lancet HIV, 2026